This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
No Items In Cart
West’s Graham Reynolds will present “An Integrated Approach to Biologic Drug Delivery Systems: Meeting the needs of the patient, and optimizing drug product performance,” at the Drug Delivery Partnerships meeting in Las Vegas, on January 25, 2012.
Graham will speak at a session entitled “Maximize the potential of your drug delivery system through drug device combination products,” chaired by Phil Green, Senior Director Drug Delivery Devices at Merck.
The presentation will focus on the importance of considering four key elements of an integrated drug delivery system and the critical interfaces between them. These four elements are:
West is uniquely positioned to understand and support this need, combining leadership in drug containment systems with device development and manufacturing expertise, and a network of industry partnerships aimed at ensuring optimum packaging and delivery systems for today’s sophisticated drug products. Examples of solutions will be briefly discussed, including Daikyo Crystal Zenith® containment systems and the SmartDose® electronic patch injector, which is an ideal example of an integrated packaging and delivery system that meets a growing market need.
VP & GM, Global Biologics
610 594 2935
West markets SmartDose® as a multi-component system only. Final assembly of the prefilled component is completed by the pharmaceutical company. SmartDose® is a registered trademark of Medimop Medical Projects Ltd., a subsidiary of West Pharmaceutical Services, Inc.
Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.